Sarcoma  >>  pidilizumab (CT-011)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pidilizumab (CT-011) / CureTech
NCT01386502: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Withdrawn
1
0
US
p53: 264-272 peptide, CT-011
National Cancer Institute (NCI)
Breast Cancer, Colon Cancer, Pancreatic Cancer, Sarcoma, Ovarian Cancer
 
10/11

Download Options